Share on StockTwits

U.S. Physical Therapy (NASDAQ:USPH) Director Mark J. Brookner sold 549 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $35.82, for a total value of $19,665.18. Following the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $1,791,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

U.S. Physical Therapy (NASDAQ:USPH) traded up 0.20% on Friday, hitting $35.75. The stock had a trading volume of 12,895 shares. U.S. Physical Therapy has a 52-week low of $27.80 and a 52-week high of $37.25. The stock has a 50-day moving average of $35.38 and a 200-day moving average of $33.39. The company has a market cap of $437.4 million and a P/E ratio of 32.09.

U.S. Physical Therapy (NASDAQ:USPH) last announced its earnings results on Thursday, August 7th. The company reported $0.52 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.08. The company had revenue of $66.90 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter last year, the company posted $0.42 earnings per share. U.S. Physical Therapy’s revenue was up 16.9% compared to the same quarter last year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, September 5th. Investors of record on Monday, August 18th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 14th.

Separately, analysts at Jefferies Group raised their price target on shares of U.S. Physical Therapy from $38.00 to $40.00 in a research note on Friday, August 8th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. U.S. Physical Therapy currently has an average rating of “Buy” and an average target price of $36.80.

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provides pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with Analyst Ratings Network's FREE daily email newsletter.